Funding for this research was provided by:
National Institutes of Health (CA180820, CA180844, CA189859, CA180864, CA180794, CA180795, CA180828)
Canadian Cancer Society Research Institute (18491)
Received: 19 January 2018
Accepted: 23 January 2018
First Online: 31 January 2018
Compliance with ethical standards
: Dr. E. Rakovitch has received research grant funding from Genomic Health Inc. FL Baehner has received remuneration and owns stock in Genomic Health Inc. M Crager owns stock in Genomic Health Inc. S Badve has received a speaker honorarium from Genomic Health Inc., Genentech, and MSD. S Shak has received remuneration and owns stock in Genomic Health Inc. LJ Solin is an advisory board member of Genomic Health Inc., with no compensation received. The other authors have no conflict of interest to declare.